AV

Amanda Venditti

Amanda has 10+ years of experience writing for various audiences on a wide range of topics for start-ups and national brands. Amanda writes about are growth marketing, branding, DTC marketing, health, wellness, skincare, beauty, women's health, motherhood, parenting, home and garden, sleep, meditation, fitness, and lifestyle topics.

https://amandavenditti.com/

Covers

Publications

  • The Everymom
    2 articles

Writes Most On

PostpartumDepressionLicensedPsychotherapistPostpartumDepressionPillFirstPillToTreatPPDOBGYNGeneralAntidepressantsNewMothersSuicidePreventionHotlinePanicAttacksSleepDisruptionMAVIDAHealthPPDLexieBelleBrexanoloneMothersAnxietyManageableTreatmentMaternalHealthBabyBluesGuiltMentalIllnessDrSarahOreckFastActingMedicationMedicalProfessionalsCEOExpectationsBreakthroughTreatmentReliefMaternalMentalHealthFounderUnderstandingPostpartumDepressionAntidepressantsZurzuvaeStigmaOralPillClinicalDiagnosisIntravenousInfusionTalktherapyHormonalChangesFDADrCandiceWoodMentalHealthProfessionalsFastActingTreatmentCOSTSuicidalThoughtsTreatmentHomeTreatmentShameWomenMadeWellSymptomsOfPPD
  • Most Popular
  • Recent Work
  • Requests
  • —The Everymom
  • FDA Approves First Pill to Treat Postpartum Depression: Experts Share What You Need to Know
    8 Aug 2023—The Everymom
    Postpartum depression (PPD), a severe and life-threatening mental illness, affects a staggering number of new mothers, with recent statistics revealing that 1 in 7 new mothers will experience PPD in the 12 months following childbirth. Finally, a new breakthrough treatment option has arrived. The U.S. Food and Drug Administration announced the first-ever oral pill designed to address postpartum depression (PPD) in the United States. Until now, treatment for severe PPD was only available...

People Also Viewed